Abraham Avigdor

The Chaim Sheba Medical Center, Israel

Dr. Abraham Avigdor is the director of the Institute of Hematology at Sheba Medical Center. He was the chairman of The Israeli Lymphoma Study Group between 2011 and 2018. He was trained in Internal Medicine and Hematology at Sheba Medical Center, and did his post-doctoral fellowship at Tsvee Lapidot’s Lab at The Weizmann Institute, studying normal hematopoietic and leukemic stem cell development and migration. Dr. Avigdor is a medical Hemato-oncologist who focuses on the care of patients with lymphoma, and has clinical expertise in all types of lymphomas. His current clinical research focuses on the integration of CAR T-cells therapy into the modern management of non-Hodgkin lymphomas. He is also involved in the clinical research of PET/CT as a prognostic tool in Hodgkin and non-Hodgkin lymphomas and the development of new therapy regimens, integrating biological and immunological agents in lymphomas. He has international collaborations with many research groups, including the LYSA (Lymphoma Study Association in France), EMCL (European Mantle Cell Lymphoma Network) and the International Study Group on PET in Lymphoma and Myeloma.